Parul Bhandari - May 18, 2022 Form 4 Insider Report for NATIONAL RESEARCH CORP (NRC)

Role: Director
Signature: /s/ Parul Bhandari, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC
Stock symbol: NRC
Transactions as of: May 18, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/20/2022, 04:50 PM
Previous filing: Jan 4, 2022
Next filing: Sep 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRC	Director Stock Option (Right to Buy)	Award	$0	+12.1K		$0.00	12.1K	May 18, 2022	Common Stock	12.1K	$32.46	Direct	F1
transaction	NRC	Director Stock Option (Right to Buy)	Award	$0	+12.1K		$0.00	12.1K	May 18, 2022	Common Stock	12.1K	$32.46	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2022 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.
F2	This award is a discretionary grant to the reporting person made under the Plan on the date of the Issuer's 2021 annual shareholder meeting in connection with the reporting person's appointment as a director of the Issuer. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

Content

This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2022 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

This award is a discretionary grant to the reporting person made under the Plan on the date of the Issuer's 2021 annual shareholder meeting in connection with the reporting person's appointment as a director of the Issuer. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.